The presbyopia debate

Article

During the "Controversies in Cataract and Refractive Surgery" symposium, Dr Jack Holladay and Dr Theo Seiler debated the relative merits of presbyopia treatments.

During the “Controversies in Cataract and Refractive Surgery” symposium, Dr Jack Holladay and Dr Theo Seiler debated the relative merits of presbyopia treatments.

Dr Holladay argued that the ACI7000 corneal inlay (Acufocus, Inc.), which utilizes the pinhole effect to reduce the pupil size to 1.6 mm, improves the depth of field without impacting the cornea, and cited the initial 41 Acufocus implantations in Turkey; two years later, patients have 20/16 vision at near and distance, and the operating surgeon is satisfied with the results.

Dr Seiler countered by discussing the cosmetic and low light issues some patients have had with the Acufocus. He noted that we assume that what we know about the multifocality or asphericity of IOLs also holds true for the cornea. He mentioned several advantages of the aspheric hyperprolate cornea but observed that this is not a bilateral solution; he dismissed bifocal refractive treatments as there is limited prospective data, they are irreversible, and dissatisfaction is high. Monovision, he concluded, is currently the only clinically accepted approach.

 

To read OTE's full news coverage of the XXVI congress of the European Society of Cataract & Refractive Surgery, please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.